Home›Stock Screener›Gennex Laboratories›Fair Value

Gennex Laboratories Fair Value

Average Fair Value
₹58.58
Current Market Price: ₹10.24
+472.03% Price Difference

Gennex Laboratories (GENNEX) average fair value is ₹58.58 across 7 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, vs a current market price of ₹10.24 (+472.03%), fair value range ₹3.33–₹255.53.

Fair Value Analysis Export

GENNEX Fair Value vs Current Price — Valuation Summary

GENNEX average fair value, fair value range, price gap and valuation status across 7 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number. For live price and a broader fundamental view, visit GENNEX stock price BSE.

Average Fair Value
₹58.58
Current Market Price
₹10.24
Price Difference
₹48.34
Percentage Difference
+472.03%
Fair Value Range
₹3.33 - ₹255.53
Methods Used
7
Analysis based on 7 valuation methods: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number

P/E Based Valuation

Current EPS ₹0.16
Sector Avg P/E 27.52
Historical Avg P/E N/A
Average Fair Value
₹3.33

P/B Based Valuation

Book Value/Share ₹92.92
Sector Avg P/B 4.0
Historical Avg P/B N/A
Average Fair Value
₹255.53

Price-to-Sales Valuation

Revenue/Share ₹2.55
Sector Avg P/S 4.0
Fair Value
₹10.21

Asset-Based Valuation

Book Value/Share ₹92.92
Liquidation Value/Share ₹101.79
Fair Value
₹92.92

Earnings Growth Model (PEG)

Current EPS ₹0.16
Growth Rate 33.43%
Fair P/E Ratio 33.43
Fair Value
₹5.35

Peter Lynch Fair Value

Current EPS ₹0.73
Growth Rate 33.43%
Dividend Yield 0%
Lynch Factor 33.43
Fair P/E Ratio 33.43
Data Source Quarterly Data (8 years)
Fair Value (Lynch Factor Adjusted)
₹24.4

Benjamin Graham Number

Current EPS ₹0.16
Book Value/Share ₹92.92
Graham Multiplier 22.5
Current P/E 11.81
Graham Criteria 2/3
Graham Number
₹18.29
Criteria Met: P/E ≤ 15, P/B ≤ 1.5

GENNEX Fair Value Analysis — Data Sources & Coverage

Gennex Laboratories financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. Check Gennex Laboratories networth to track the company's total market size over time.

Methods Used
7
Data Year
2026
Sector
Healthcare

Available Data Sources: Financial statements, balance sheet data , sector comparisons.

Data Currency: Financial data is from the current year (2026).

GENNEX vs Healthcare Sector Peers — P/E, P/B & Market Cap

Gennex Laboratories P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Jeena Sikho Lifecare JSLL 33.24 15.78 ₹7,371
Murae Organisor MURAE 2.86 0.2 ₹41
Sat Kartar Life SATKARTAR 13.44 3.4 ₹226
KRM Ayurveda KRMAYURVED - 4.56 ₹545
Emcure Pharmaceuticals EMCURE 37.24 7.08 ₹34,821

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.